Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-02-22

Clinical Trial Update: Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether Vitamin E can prevent the side effects of isotretinoin in former and current smokers receiving isotretinoin to prevent lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)
  • Vitamin E (tocopherol)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer | Phase 3 | Status: WITHDRAWN